Literature DB >> 11306145

Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation.

J B Szeberényi1, E Pállinger, M Zsinkó, Z Pós, G Rothe, E Orsó, S Szeberényi, G Schmitz, A Falus, V László.   

Abstract

Histamine, a principal mediator in various physiological and pathological cell functions is synthesized from L-histidine exclusively by histidine decarboxylase, an enzyme, which is expressed in many tissues of mammalian organism. Histamine plays a role in various cellular functions, including cell differentiation. The aim of this study was to determine the presence and to characterize the role of the endogenously produced histamine during in vitro dendritic cell (DC) differentiation induced by interleukin-4 (IL-4) and granulocyte-monocyte colony stimulating factor (GM-CSF). The changes in intracellular histamine content, biosynthesis and gene expression of histidine decarboxylase were investigated during this process. One also studied how histamine receptor antagonists and a histamine synthesis blocker influence the expression of differentiation antigens on the DC during in vitro maturation. During in vitro differentiation parallel culture incubations were performed by adding H1 receptor antagonist triprolidine, H2 receptor antagonist tiotidine, the tamoxifene derivate DPPE which blocks the intracellular binding of histamine, and an irreversible blocker of histidine decarboxylase, alpha-fluoromethyl histamine (alpha-FMH). The results show simultaneous increase in both histidine decarboxylase level and histamine content during differentiation of elutriated monocytes toward DC. Both blockade of de novo histamine production (by alpha-FMH) and inhibition of histamine binding (by H1 and H2 receptor antagonists, triprolidine and tiotidine, respectively) markedly decreased CD40 expression and that of CD45 from the 3rd day of treatment. DPPE by disturbing intracellular interaction of histamine with cytochrome P-450 moieties was able to decrease the expression of CD45, CD86, HLA-DR, CD33, CD40 and CD11c. Based on the data it is suggested that endogenous histamine is actively synthesized during cytokine-induced in vitro DC differentiation. The functional relevance and autocrine and paracrine action of endogenously produced histamine is supported by the data showing that inhibition of histamine synthesis by HDC, blocking of histamine binding by both 'extracellular' histamine receptors (by specific antagonists, triprolidine and tiotidine) and 'intracellular' antagonists (DPPE) disturb the differentiation of DC. This conclusion is supported by the fact, that by the inhibition of histamine acting in an autocrine/paracrine way, the expression pattern of differentiation markers on DC is markedly changed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306145     DOI: 10.1016/s0165-2478(01)00184-5

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

1.  Modulation of tissue inflammatory response by histamine receptors in scorpion envenomation pathogenesis: involvement of H4 receptor.

Authors:  Amal Lamraoui; Sonia Adi-Bessalem; Fatima Laraba-Djebari
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

2.  Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization.

Authors:  A Mazzoni; H A Young; J H Spitzer; A Visintin; D M Segal
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

3.  Histamine and prostaglandin E up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-gamma-induced CXCL10 production by immature human dendritic cells.

Authors:  Anne McIlroy; Gersende Caron; Simon Blanchard; Isabelle Frémaux; Dorothée Duluc; Yves Delneste; Alain Chevailler; Pascale Jeannin
Journal:  Immunology       Date:  2006-04       Impact factor: 7.397

4.  Identification of histamine receptor subtypes in skeletal myogenesis.

Authors:  Yan Chen; Vasily Stegaev; Vesa-Petteri Kouri; Tarvo Sillat; Paul L Chazot; Holger Stark; Jian Guo Wen; Yrjö T Konttinen
Journal:  Mol Med Rep       Date:  2014-12-10       Impact factor: 2.952

Review 5.  Update on Dendritic Cell-Induced Immunological and Clinical Tolerance.

Authors:  Carolina Obregon; Rajesh Kumar; Manuel Antonio Pascual; Giuseppe Vassalli; Déla Golshayan
Journal:  Front Immunol       Date:  2017-11-20       Impact factor: 7.561

Review 6.  Molecular Regulation of Histamine Synthesis.

Authors:  Hua Huang; Yapeng Li; Jinyi Liang; Fred D Finkelman
Journal:  Front Immunol       Date:  2018-06-20       Impact factor: 7.561

7.  Specific histamine regulating activity of surface-modified yeast vacuoles by histamine- binding protein and its immune-enhancing effect.

Authors:  Hyeweon Jang; Yang-Hoon Kim; Jiho Min
Journal:  Microb Biotechnol       Date:  2022-08-10       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.